RCYC
MDT icon

Richard C. Young & Co’s Medtronic MDT Stock Holding History

Richard C. Young & Co’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-140,201
Closed -$12.2M – 95
2025
Q2 		$12.2M Buy
140,201
+141
+0.1% +$12K 1.21% 36
2025
Q1 		$12.6M Sell
140,060
-561
-0.4% -$50.2K 1.35% 34
2024
Q4 		$11.2M Buy
140,621
+1,389
+1% +$120K 1.22% 38
2024
Q3 		$12.5M Buy
139,232
+3,634
+3% +$306K 1.37% 38
2024
Q2 		$10.7M Sell
135,598
-177
-0.1% -$14.5K 1.3% 41
2024
Q1 		$11.8M Buy
135,775
+9,547
+8% +$815K 1.49% 34
2023
Q4 		$10.4M Sell
126,228
-6,394
-5% -$487K 1.39% 40
2023
Q3 		$10.4M Buy
132,622
+1,348
+1% +$113K 1.48% 37
2023
Q2 		$11.6M Buy
131,274
+5,110
+4% +$440K 1.59% 33
2023
Q1 		$10.2M Buy
126,164
+47,905
+61% +$3.9M 1.4% 36
2022
Q4 		$6.08M Sell
78,259
-43,090
-36% -$3.49M 0.81% 52
2022
Q3 		$9.8M Buy
121,349
+828
+0.7% +$74.4K 1.5% 31
2022
Q2 		$10.8M Buy
120,521
+2,962
+3% +$300K 1.4% 30
2022
Q1 		$13M Buy
117,559
+2,559
+2% +$270K 1.67% 24
2021
Q4 		$11.9M Buy
115,000
+3,047
+3% +$353K 1.5% 26
2021
Q3 		$14M Sell
111,953
-2,548
-2% -$330K 1.93% 20
2021
Q2 		$14.2M Buy
114,501
+2,658
+2% +$334K 1.81% 21
2021
Q1 		$13.2M Buy
111,843
+6,542
+6% +$767K 1.75% 21
2020
Q4 		$12.3M Buy
105,301
+1,791
+2% +$197K 1.88% 19
2020
Q3 		$10.8M Buy
103,510
+1,647
+2% +$165K 1.73% 20
2020
Q2 		$9.34M Sell
101,863
-1,144
-1% -$110K 1.56% 26
2020
Q1 		$9.29M Buy
103,007
+2,006
+2% +$213K 1.8% 22
2019
Q4 		$11.5M Buy
101,001
+2,335
+2% +$256K 1.91% 20
2019
Q3 		$10.7M Buy
98,666
+1,592
+2% +$166K 1.93% 19
2019
Q2 		$9.45M Buy
97,074
+2,382
+3% +$217K 1.79% 20
2019
Q1 		$8.63M Buy
+94,692
New +$8.48M 1.65% 23

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Richard C. Young & Co's MDT Position: Q3 2025 in Review

Richard C. Young & Co sold out of Medtronic (MDT) in Q3 2025, closing a stake of 140,201 shares — an estimated $12.2M sold.

Richard C. Young & Co first reported a position in MDT in Q1 2019 and held it in 26 quarters. The position peaked at $14.2M in Q2 2021. 2,170 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Richard C. Young & Co reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • Richard C. Young & Co sold 140,201 Medtronic shares in Q3 2025, an estimated $12.2M.
  • Richard C. Young & Co first reported a position in Medtronic in Q1 2019 and held it in 26 quarters.
  • Richard C. Young & Co's Medtronic position peaked at $14.2M in Q2 2021.
  • 2,170 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Richard C. Young & Co's 13F filing for Q3 2025, filed 12 Nov 2025.